Home
Novelix Pharmaceuticals Ltd Share Price History
Novelix Pharmaceuticals Ltd
BSE : 05 May, 2025
26.610.0 (0.0%)
Prev Close
26.6
Open Price
26.6
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
1
Today's High / Low
26.6 / 26.6
52 WK High / Low
26.6 / 17.2
Market Price of Novelix Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Monitoring Novelix Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 0.04 |
| YoY Gr. | - |
| Net Profit (Cr.) | 0 |
| BVPS | 14.25 |
Key Financial Parameters
| Parameter | 2013 |
|---|---|
| Return on Capital Emp. % | 5.05 |
| Op. Profit Mgn % | 13.76 |
| Net Profit Mgn % | 6.38 |
| Debt to Equity % | 0.01 |
Latest Shareholding
Promoters Holdings Over Time
About Novelix Pharmaceuticals Ltd
- Trimurthi Limited was formerly incorporated on December 13, 1994 with the name Trimurthi Securities Ltd. The name of the Company thereafter got changed from Trimurthi Securities Ltd to Trimurthi Drugs & Pharmaceuticals Ltd. In September 2006, as per the Scheme of Arrangement, the erstwhile Trimurthi Drugs & Pharmaceuticals Ltd amalgamated with the Company.
- Also, the name of the Company was changed to Trimurthi Drugs & Pharmaceuticals Ltd and again to Trimurthi Limited in May, 2016. Initially, the company was engaged in finance and investments in securities.
- They ceased their operations due to the high volatility in the markets and voluntarily got de-registered as Non-Banking financial company.
- Thereafter, the company explored the possibilities of entering into pharmaceutical and drug industry by way of diversification.
Popular Search
FAQs for Novelix Pharmaceuticals Ltd Share Price History
What are the key events that typically impact Novelix Pharmaceuticals Ltd's share price history?
Key events that impact Novelix Pharmaceuticals Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Novelix Pharmaceuticals Ltd's share price history?
Stock splits reduce the nominal price of Novelix Pharmaceuticals Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Novelix Pharmaceuticals Ltd?
Dividends can influence Novelix Pharmaceuticals Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Novelix Pharmaceuticals Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Novelix Pharmaceuticals Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Novelix Pharmaceuticals Ltd’s share price history?
To understand Novelix Pharmaceuticals Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
